Free Trial

FibroBiologics (FBLG) SEC Filings & 10K Form

FibroBiologics logo
$2.81 -0.27 (-8.77%)
(As of 11/14/2024 ET)

Recent FibroBiologics SEC Filings

DateFilerForm TypeView
09/24/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
6:47 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:51 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:53 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:54 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:55 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
08/12/2024
8:57 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:21 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
10:23 AM
FibroBiologics (Filer)
Form DEF 14A
07/08/2024
10:25 AM
FibroBiologics (Filer)
Form DEFA14A
07/08/2024
10:27 AM
FibroBiologics (Filer)
Form ARS
06/27/2024
4:16 PM
FibroBiologics (Filer)
Form PRE 14A
06/27/2024
6:22 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
5:11 AM
FibroBiologics (Filer)
Form 424B4
06/25/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
06/06/2024
9:58 AM
FibroBiologics (Filer)
Form RW
06/04/2024
1:36 PM
FibroBiologics (Filer)
Form S-1/A
05/14/2024
3:05 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
7:56 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
03/26/2024
4:28 PM
FibroBiologics (Filer)
Form S-1/A
03/15/2024
3:09 PM
FibroBiologics (Filer)
Form S-1/A
02/29/2024
4:09 PM
FibroBiologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
8:57 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
8:01 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2024
5:28 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2024
5:30 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2024
4:18 PM
FibroBiologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/08/2024
8:27 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
6:32 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
11:15 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:40 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2024
6:45 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2024
4:56 PM
Andersen Mark C. (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
3:52 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)

Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025

Click here to reserve your seat at the Crypto Community Summit.
02/01/2024
8:04 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
8:45 PM
FibroBiologics (Filer)
Form 424B4
01/30/2024
12:20 PM
FibroBiologics (Filer)
Form CERT
01/24/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/24/2024
2:36 PM
FibroBiologics (Filer)
Form S-1/A
01/24/2024
10:11 AM
FibroBiologics (Filer)
Form 8-A12B
01/22/2024
3:14 PM
FibroBiologics (Filer)
Form S-1/A
01/12/2024
3:05 PM
FibroBiologics (Filer)
Form S-1/A
12/14/2023
3:36 PM
FibroBiologics (Subject)
Form FWP
12/07/2023
3:28 PM
FibroBiologics (Filer)
Form S-1/A
12/04/2023
8:15 AM
FibroBiologics (Filer)
Form S-1/A
11/30/2023
3:44 PM
FibroBiologics (Filer)
Form S-1/A
11/27/2023
7:16 PM
FibroBiologics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBLG) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners